Broad Institute Executive and Leadership Team

Emme Handy, the Chief Financial Officer at Broad Institute, governs the fiscal strategy and resource management essential for sustaining long-term biomedical research. Directing financial planning and grant administration, the Chief Financial Officer ensures that capital flows efficiently toward high-priority genomic projects. This role involves managing complex budgetary frameworks and reporting requirements to maintain institutional transparency and compliance. By optimizing financial performance, Emme Handy provides the necessary funding stability for researchers to pursue ambitious scientific goals. The Chief Financial Officer collaborates with leadership to evaluate investment opportunities in new technologies and laboratory expansions. Through rigorous fiscal oversight, Handy drives the economic health of the organization, ensuring that financial resources directly support the discovery of new treatments for human diseases while maintaining sustainable growth across all research programs.

Dan Shore, the Chief Operating Officer at Broad Institute, manages the daily administrative and operational functions that sustain high-impact scientific research. Overseeing facility management and institutional logistics, the Chief Operating Officer ensures that laboratory environments meet the rigorous demands of genomic discovery. This leadership role involves coordinating cross-departmental workflows to maximize resource allocation and operational throughput. By streamlining internal processes, Dan Shore supports the seamless execution of complex research projects and clinical initiatives. The Chief Operating Officer maintains alignment between administrative support teams and scientific staff to foster a productive research culture. Through careful oversight of institutional infrastructure, Shore drives the operational stability required for long-term scientific success, ensuring that all organizational activities remain focused on the core mission of developing innovative therapies for human diseases.

Jennifer Hopkins, the Chief Information Officer at Broad Institute, directs the digital infrastructure supporting large-scale genomic research. Managing complex data pipelines, the Chief Information Officer ensures secure access to high-performance computing resources for scientists across the organization. This role involves architecting scalable cloud solutions that facilitate rapid data analysis and cross-institutional collaboration. By optimizing information systems, Jennifer Hopkins enables researchers to process massive biological datasets with precision and speed. The Chief Information Officer maintains robust cybersecurity protocols to protect sensitive genetic information while supporting the broader mission of finding new treatments for human diseases. Through strategic technology investments, Hopkins drives the digital transformation necessary for modern biomedical breakthroughs, ensuring that computational capabilities remain at the forefront of global research standards and operational efficiency.

Emily Botelho, the Chief of Staff & To David R Liu Senior Advisor at Broad Institute, coordinates strategic initiatives and facilitates communication between executive leadership and research teams. Managing the flow of information and project priorities, the Chief of Staff & To David R Liu Senior Advisor ensures that organizational goals remain aligned with the broader scientific mission. This role involves synthesizing complex data into actionable insights for senior management to support informed decision-making. By streamlining executive workflows, Emily Botelho enables the leadership team to focus on critical research breakthroughs and institutional growth. The Chief of Staff & To David R Liu Senior Advisor maintains strong relationships across departments to ensure operational cohesion. Through proactive management of strategic priorities, Botelho drives the execution of key initiatives that advance the development of new therapies for human diseases.

Sarah Cox, the Chief People Officer at Broad Institute, leads the human capital strategy to attract and retain top-tier scientific talent. Overseeing talent acquisition, professional development, and organizational culture, the Chief People Officer ensures that the workforce remains equipped to tackle complex genomic challenges. This role involves designing inclusive programs that foster innovation and collaboration among diverse research teams. By cultivating a high-performance environment, Sarah Cox supports the recruitment of world-class scientists and administrative professionals. The Chief People Officer manages performance systems and employee engagement initiatives to maintain institutional excellence. Through strategic workforce planning, Cox drives the development of a resilient and motivated team, ensuring that the organization possesses the human expertise required to advance the discovery of new treatments for human diseases on a global scale.

Lee McGuire, the Chief Communications Officer (Cco) at Broad Institute, manages the institutional narrative and public engagement strategies. Directing internal and external communications, the Chief Communications Officer (Cco) ensures that the impact of genomic research reaches key stakeholders, including the scientific community and the general public. This role involves crafting messaging that highlights the importance of new therapies and the organization's role in biomedical innovation. By overseeing media relations and digital outreach, Lee McGuire builds awareness and support for complex research initiatives. The Chief Communications Officer (Cco) collaborates with leadership to maintain a consistent and transparent institutional voice. Through strategic communication efforts, McGuire drives public understanding of the organization's mission, ensuring that the value of scientific discovery is clearly articulated to support the ongoing search for new treatments for human diseases.

Ellen Law, the Senior Advisor To the Director at Broad Institute, provides high-level guidance on institutional strategy and long-term research objectives. Supporting the Director in shaping the scientific vision, the Senior Advisor To the Director evaluates emerging trends in genomics to identify new opportunities for therapeutic discovery. This role involves facilitating high-stakes partnerships and representing the organization in critical external discussions. By providing expert analysis on complex research programs, Ellen Law ensures that institutional efforts remain focused on high-impact biological breakthroughs. The Senior Advisor To the Director collaborates with other executive leaders to integrate strategic goals across all departments. Through insightful advisory work, Law drives the development of long-term initiatives that position the organization as a leader in the field, ultimately supporting the mission to find new treatments for human diseases.